GLP-1RA Liraglutide and Semaglutide Improves Obesity-Induced Muscle Atrophy via SIRT1 Pathway

Jie Xiang; Liyan Qin; Jinling Zhong; Ning Xia; Yuzhen Liang

doi:10.2147/dmso.s425642

journal article Open Access Aug 01, 2023

GLP-1RA Liraglutide and Semaglutide Improves Obesity-Induced Muscle Atrophy via SIRT1 Pathway

Jie Xiang

Liyan Qin

Jinling Zhong Ning Xia

Yuzhen Liang

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Vol. Volume 16 pp. 2433-2446 · Informa UK Limited

View at Publisher Save 10.2147/dmso.s425642

Topics

No keywords indexed for this article. Browse by subject →

References

59

[1]

Yang Healthcare (2022) 10.3390/healthcare10091616

[2]

Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement

Lorenzo M. Donini, Luca Busetto, Stephan C. Bischoff et al.

Obesity Facts 2022 10.1159/000521241

[3]

Roubenoff Obes Res (2004) 10.1038/oby.2004.107

[4]

Zhang BMC Geriatr (2019) 10.1186/s12877-019-1195-y

[5]

Wu J Clin Invest (2017) 10.1172/jci88880

[6]

Lipid modulation of skeletal muscle mass and function

Christopher Lipina, Harinder S Hundal

Journal of Cachexia, Sarcopenia and Muscle 2017 10.1002/jcsm.12144

[7]

Batsis Nat Rev Endocrinol (2018) 10.1038/s41574-018-0062-9

[8]

El Bizri Proc Nutr Soc (2020) 10.1017/s0029665120000075

[9]

Incretin hormones: Their role in health and disease

Michael A Nauck, Juris J. Meier

Diabetes, Obesity and Metabolism 2018 10.1111/dom.13129

[10]

Kim Diabetes Metab Syndr Obes (2017) 10.2147/dmso.s132707

[11]

Jendle Diabetes Obes Metab (2009) 10.1111/j.1463-1326.2009.01158.x

[12]

Perna Aging Clin Exp Res (2016) 10.1007/s40520-015-0525-y

[13]

Blundell Diabetes Obes Metab (2017) 10.1111/dom.12932

[14]

Ozeki Medicines (2022) 10.3390/medicines9090047

[15]

Milne Curr Opin Chem Biol (2008) 10.1016/j.cbpa.2008.01.019

[16]

Gurd Appl Physiol Nutr Metab (2011) 10.1139/h11-070

[17]

Lee J Biol Chem (2013) 10.1074/jbc.m113.489716

[18]

Li Front Pharmacol (2022) 10.3389/fphar.2022.859723

[19]

Xu Diabetes (2014) 10.2337/db14-0263

[20]

Lee Cell Stress Chaperones (2014) 10.1007/s12192-013-0490-3

[21]

Jeon Int J Mol Med (2019) 10.3892/ijmm.2019.4272

[22]

Kalinkovich Ageing Res Rev (2017) 10.1016/j.arr.2016.09.008

[23]

Tomlinson Biogerontology (2016) 10.1007/s10522-015-9626-4

[24]

Sishi Exp Physiol (2011) 10.1113/expphysiol.2010.054189

[25]

Boozer Am J Physiol (1995) 10.1152/ajpendo.1995.268.4.e546

[26]

Rothwell Clin Endocrinol Metab (1984) 10.1016/s0300-595x(84)80032-8

[27]

Levin Am J Physiol Regul Integr Comp Physiol (2002) 10.1152/ajpregu.2002.282.1.r46

[28]

Listenberger Proc Natl Acad Sci U S A (2003) 10.1073/pnas.0630588100

[29]

Ladenheim Drug Des Devel Ther (2015) 10.2147/dddt.s58459

[30]

Müller Nat Rev Drug Discov (2022) 10.1038/s41573-021-00337-8

[31]

van Can Int J Obes (2014) 10.1038/ijo.2013.162

[32]

Secher J Clin Invest (2014) 10.1172/jci75276

[33]

Gabery JCI Insight (2020) 10.1172/jci.insight.133429

[34]

The GLP-1 Analogs Liraglutide and Semaglutide Reduce Atherosclerosis in ApoE−/− and LDLr−/− Mice by a Mechanism That Includes Inflammatory Pathways

Günaj Rakipovski, Bidda Rolin, Jane Nøhr et al.

JACC: Basic to Translational Science 2018 10.1016/j.jacbts.2018.09.004

[35]

You Front Pharmacol (2021) 10.3389/fphar.2021.646489

[36]

Connolly Neuromuscul Disord (2001) 10.1016/s0960-8966(01)00232-2

[37]

Rafael Mamm Genome (2000) 10.1007/s003350010149

[38]

Pahor J Nutr Health Aging (2009) 10.1007/s12603-009-0204-9

[39]

Pasetto PLoS One (2018) 10.1371/journal.pone.0198089

[40]

Frontera Calcif Tissue Int (2015) 10.1007/s00223-014-9915-y

[41]

Lauterbach Pflugers Arch (2017) 10.1007/s00424-017-1955-5

[42]

Hulver Am J Physiol Endocrinol Metab (2003) 10.1152/ajpendo.00514.2002

[43]

Andrikopoulos Am J Physiol Endocrinol Metab (2008) 10.1152/ajpendo.90617.2008

[44]

Ayala Dis Model Mech (2010) 10.1242/dmm.006239

[45]

Schiaffino FEBS J (2013) 10.1111/febs.12253

[46]

Maliszewska Pol Arch Intern Med (2019) 10.20452/pamw.15025

[47]

Milan Nat Commun (2015) 10.1038/ncomms7670

[48]

Sandri Cell (2004) 10.1016/s0092-8674(04)00400-3

[49]

Knight Skelet Muscle (2011) 10.1186/2044-5040-1-29

[50]

Klip J Biol Chem (2019) 10.1074/jbc.rev119.008351

Showing 50 of 59 references

Cited By

84

Impact of Semaglutide on fat mass, lean mass and muscle function in patients with obesity: The SEMALEAN study

Mathieu Alissou, Thomas Demangeat · 2025

Diabetes, Obesity and Metabolism

Glucagon-like peptide-1 receptor agonists and muscle mass effects

Alexandr Ceasovschih, Andreea Asaftei · 2025

Pharmacological Research

Spotlight on the Mechanism of Action of Semaglutide

Ilias Papakonstantinou, Konstantinos Tsioufis · 2024

Current Issues in Molecular Biology

Comparative effects of incretin-based therapy on doxorubicin-induced nephrotoxicity in rats: the role of SIRT1/Nrf2/NF-κB/TNF-α signaling pathways

Sandy R. Botros, Asmaa I. Matouk · 2024

Frontiers in Pharmacology

Metrics

84

Citations

59

References

Details

Published: Aug 01, 2023
Vol/Issue: Volume 16
Pages: 2433-2446
License: View

Authors

J

Jie Xiang

From the State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University (W.G., W.L., J.H., R.C., C.T., T.W., S.L., Jin-lin Wang, N.Z., J.H., W.L.), the Departments of Thoracic Oncology (W.L.), Thoracic Surgery and Oncology (J.H.), and Emergency Medicine (Z.L.), First Affiliated Hospital of Guangzhou Medical University, and Guangzhou Eighth People’s Hospital,...

Department of Pharmacology, Johannes Gutenberg University Medical Center, 55131 Mainz, Germany

Y

Yuzhen Liang

Cite This Article

Jie Xiang, Liyan Qin, Jinling Zhong, et al. (2023). GLP-1RA Liraglutide and Semaglutide Improves Obesity-Induced Muscle Atrophy via SIRT1 Pathway. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Volume 16, 2433-2446. https://doi.org/10.2147/dmso.s425642

GLP-1RA Liraglutide and Semaglutide Improves Obesity-Induced Muscle Atrophy via SIRT1 Pathway

You May Also Like